FDA Drug Application (022350) for ONGLYZA by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number022350
Product Number001
FormTABLET;ORAL
DosageEQ 2.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameONGLYZA
Active IngredientSAXAGLIPTIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient SAXAGLIPTIN HYDROCHLORIDE2


Back to FDA Applications sponsored by ASTRAZENECA AB